Clinical Trials Browser

Phase 3 × R-CHOP protocol × 90 days × Clear all

NCT06549595 2026-05-20

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Phase 3 Recruiting

Lymphoma, Follicular

NCT05888493 2026-04-17

LEDA

Phase 3 Active not recruiting

Lymphoma, Follicular, Recurrence